Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Idaverine SCHEMBL7286939 | 1.00 | TSHR (0.46) | TSHRCYP3A4ADRB2HTR1AADRA2A | |
| Idaverine SCHEMBL10340527 | 0.99 | CYP3A4 (0.47) | TSHRCYP3A4ADRB2HTR1AADRA2A | |
| SCHEMBL10868814 | 0.93 | TSHR (0.45) | TSHRCYP3A4ADRB2HTR1AADRA2A | |
| SCHEMBL10483403 | 0.93 | CYP3A4 (0.46) | TSHRCYP3A4ADRB2HTR1AADRA2A | |
| SCHEMBL10483413 | 0.91 | TSHR (0.45) | TSHRCYP3A4ADRB2HTR1AADRA2A | |
| SCHEMBL10483315 | 0.91 | TSHR (0.47) | TSHRCYP3A4ADRB2HTR1AADRA2A | |
| SCHEMBL10483532 | 0.90 | TSHR (0.51) | TSHRCYP3A4ADRB2HTR1AADRA2A | |
| SCHEMBL10483436 | 0.90 | OPRD1 (0.35) | TSHRCYP3A4ADRB2HTR1AADRA2A | |
| SCHEMBL10483439 | 0.90 | OPRD1 (0.35) | TSHRCYP3A4ADRB2HTR1AADRA2A | |
| SCHEMBL10483450 | 0.89 | HRH3 (0.39) | TSHRCYP3A4ADRB2HTR1AADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116368243-A | Replication stress pathway agent compositions and methods for treating cancer | 无界生物公司 | 2023-06-30 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| EP-2305314-A2 | Remodelling and glycoconjugation of antibodies | BioGeneriX AG (DE) | 2011-04-06 | — | — | EP | claimed |
| EP-2292271-A2 | Remodelling and glycoconjugation of an antibody | BioGeneriX AG (DE) | 2011-03-09 | — | — | EP | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| CN-122029161-A | Crystalline forms of PI3K inhibitors and uses thereof | 蝎子疗法股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4626492-A1 | MATRICES FOR WOUND HEALING | Regenics AS (NO) | 2025-10-08 | — | — | EP | disclosed |
| EP-3866818-B1 | USE OF FISH EGG CELLULAR EXTRACTT FOR WOUND HEALING | REGENICS AS (NO) | 2025-07-23 | — | — | EP | disclosed |
| CN-118459413-A | Compositions and methods for treating cancer | 加利福尼亚大学董事会 | 2024-08-09 | — | — | CN | disclosed |
| WO-2024116120-A1 | MATRICES FOR WOUND HEALING | REGENICS AS (NO) | 2024-06-06 | — | — | WO | disclosed |
| WO-1993007902-A1 | ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS | RICHARDSON-VICKS, INC. (US) | 1993-04-29 | — | — | WO | disclosed |
| WO-1993007903-A1 | ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS | RICHARDSON-VICKS, INC. (US) | 1993-04-29 | — | — | WO | disclosed |
| EP-0351897-A2 | Skin penetration system for salts of amine-functional drugs | THE PROCTER & GAMBLE COMPANY (US) | 1990-01-24 | — | — | EP | disclosed |
| US-4889849-A | GASTROINTESTINAL, UROGENITAL, AND RESPIRATORY DISORDERS; SIDE EFFECT REDUCTION | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1989-12-26 | — | — | US | disclosed |
| EP-0177078-A1 | Spasmolytically active tertiary amine derivatives and method of preparing the same | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1986-04-09 | — | — | EP | disclosed |